| Presented by: | North American Center for Continuing Medical Education, LLC (NACCME) |
| Lecturer | Jeffrey M. Weinberg, MD, John A. Goldman, MD, FACR, FACP, CCD and David Calabrese, RPh, MHP |
| Approximate duration: | 1 hr. |
| Summary points: | This audiovisual presentation describes the clinical and economic burden of moderate-to-severe psoriasis and psoriatic arthritis, treatment protocols that incorporate therapeutic efficacy measures and foster communication between specialists and other providers, benefits and limitations of biologic therapies for moderate-to-severe psoriasis and psoriatic arthritis, and ways to incorporate biologic therapies into evidence-based treatment algorithms. |
| Accreditation: | North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-08-027-H01-P).
Expiration Date: March 12, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
Moderate-to-Severe Psoriasis and Psoriatic Arthritis: Reducing the Clinical and Economic Burden Through Effective Treatment Protocols
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
